August 3, 2004Circulation965 citationsOpen Access

Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

Does dalteparin 5000 IU once daily prevent venous thromboembolism in acutely ill medical patients?

Population

Acutely ill medical patients

Intervention

Dalteparin 5000 IU once daily

Comparator

Placebo

Outcome

Venous thromboembolismhard clinical

Dalteparin 5000 IU once daily reduces the rate of venous thromboembolism in acutely ill medical patients with a low risk of bleeding.

Dalteparin 5000 IU once daily halved the rate of venous thromboembolism with a low risk of bleeding.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Leizorovicz et al. (Tue,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Demander à l'IA

Bookmark

View Full Paper